Hosted on MSN
Nobel winner’s lab notches another breakthrough: AI-designed antibodies that hit their targets
Researchers from Nobel Laureate David Baker’s lab and the University of Washington’s Institute for Protein Design (IPD) have used artificial intelligence to design antibodies from scratch — notching ...
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform ...
Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University, have developed a new vaccine strategy that has generated antibodies ...
Although it is one of the most common forms of lung cancer, non-small cell lung tumors remain difficult to treat with current therapies such as tyrosine kinase inhibitors. Efforts to develop new ...
Biocytogen introduces AI-powered RenSuper platform and industry-first fully automated antibody discovery infrastructure: Beijing, China Wednesday, May 27, 2026, 18:00 Hrs [IST] Bi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results